Scientists test if breakfast timing boosts new bleeding disorder drug
NCT ID NCT07238816
Summary
This study aims to understand how eating before and after taking a new oral medicine called Inno8 affects how the body absorbs it. It will involve 80 healthy male volunteers who will take a single dose under different fasting conditions. The main goal is to gather data to help determine the best way to take the medicine in future patient studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Altasciences Clinical LA, Inc.
RECRUITINGCypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.